The U.S. Food and Drug Administration on Thursday authorized bivalent COVID-19 boosters for children ages 6 months to 4 years.
The booster, available from both Pfizer and Moderna, was previously authorized for all ages 5 and up in October.
“More children now have the option of updating their protection against COVID-19 with a bivalent COVID-19 vaccine, and we encourage parents and caregivers of eligible individuals to consider doing so – particularly at approaching the holidays and the winter months when more time will be spent indoors,” FDA Commissioner Robert Califf said in a statement.
“As this virus has changed and immunity to previous COVID-19 vaccination wanes, the more people who keep up to date on COVID-19 vaccinations, the more benefits there will be for individuals, families and public health by helping to prevent serious illnesses, hospitalizations and deaths.”
The updated booster targets BA.4 and BA.5, which are sub-variants of the omicron variant.
Children are eligible to receive the booster at least two months after the end of their primary series or after receiving a separate booster dose.
This is a developing story. Please check for updates.